S. Custodio-Cabello

发表

Low total pathologic complete response rate to preoperative chemotherapy in patients with invasive lobular carcinomaof the breast

P. Khosravi-Shahi, L. Cabezón-Gutiérrez, S. Custodio-Cabello, 2019, Contemporary oncology.

Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: Review of the Literature and a Single-center Experience

P. Khosravi-Shahi, L. Cabezón-Gutiérrez, S. Custodio-Cabello, 2019, Cureus.

Review of risk of COVID-19 in cancer patients and their cohabitants

P. Khosravi-Shahi, L. Cabezón-Gutiérrez, S. Custodio-Cabello, 2021, International Journal of Infectious Diseases.

High-dose 8% capsaicin patch in treatment of Chemotherapy-induced peripheral neuropathy (CIPN). A Systematic review.

P. Khosravi-Shahi, L. Cabezón-Gutiérrez, S. Custodio-Cabello, 2020, Journal of pain and symptom management.

Clinical Case of Metastatic Adrenocortical Carcinoma With Unusual Evolution: Review the Literature

P. Khosravi-Shahi, L. Cabezón-Gutiérrez, A. Franco-Moreno, 2015, World journal of oncology.

Opioids for management of episodic breathlessness or dyspnea in patients with advanced disease

P. Khosravi-Shahi, L. Cabezón-Gutiérrez, S. Custodio-Cabello, 2016, Supportive Care in Cancer.

Chemotherapy Plus Bevacizumab as Neoadjuvant or Conversion Treatment in Patients with Colorectal Liver Metastases.

Miguel Martín, A. M. Muñoz Martín, E. de Ramón, 2018, Anticancer research.

Seroprevalence of SARS-CoV-2–specific antibodies in cancer outpatients in Madrid (Spain): A single center, prospective, cohort study and a review of available data

P. Khosravi-Shahi, L. Cabezón-Gutiérrez, M. García-Navarro, 2020, Cancer Treatment Reviews.

Neoadjuvant immunotherapy for dMMR/MSI-H locally advanced rectal cancer: The future new standard approach?

L. Cabezón-Gutiérrez, S. Custodio-Cabello, Magda Palka-Kotlowska, 2022, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Biomarkers of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Beyond PD-L1.

P. Khosravi-Shahi, L. Cabezón-Gutiérrez, S. Custodio-Cabello, 2021, Clinical lung cancer.

Metastatic Thymic Carcinoma with Long Survival After Treatment with Sunitinib

P. Khosravi-Shahi, L. Cabezón-Gutiérrez, A. Franco-Moreno, 2018, Cureus.

Metastatic triple negative breast cancer: Optimizing treatment options, new and emerging targeted therapies

P. Khosravi-Shahi, L. Cabezón-Gutiérrez, S. Custodio-Cabello, 2018, Asia-Pacific journal of clinical oncology.

Chemotherapy in a Breast Cancer Patient Heterozygous Carrier of Ornithine Transcarbamylase Deficiency

L. Cabezón-Gutiérrez, S. Custodio-Cabello, Magda Palka-Kotlowska, 2020, Cureus.

Survival after maximum effort cytoreductive surgery and platinum-based chemotherapy in patients with epithelial ovarian cancer, fallopian tube carcinoma and primary peritoneal carcinomatosis: Experience of a Public University Hospital in Spain

P. Khosravi-Shahi, L. Cabezón-Gutiérrez, S. Custodio-Cabello, 2019, Gaceta Mexicana de Oncolog�a.

Biomarkers of Pembrolizumab Efficacy in First-Line Advanced PD-L1 ?50% Non-Small Cell Lung Cancer Treatment

Sílvia, P. Khosravi-Shahi, L. Cabezón-Gutiérrez, 2021, Journal of Cancer Immunology.

Complete response to third-line treatment with trifluridine/tipiracil (TAS-102) in stage IV colon adenocarcinoma

L. Cabezón-Gutiérrez, V. Pacheco-Barcia, S. Custodio-Cabello, 2023, Exploration of targeted anti-tumor therapy.

Prognostic Factors of Nintedanib-docetaxel in Patients with Previously Treated Non-small-cell Lung Cancer

L. Cabezón-Gutiérrez, V. Pacheco-Barcia, S. Custodio-Cabello, 2023, Journal of Cancer Immunology.

Update on thymic epithelial tumors: a narrative review

P. Khosravi-Shahi, L. Cabezón-Gutiérrez, S. Custodio-Cabello, 2024, Mediastinum.